| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Department of Neurology (Drs. Eisensehr and Noachtar), University of Munich, Germany; the Department of Neurology (Dr. Ehrenberg and K. Korbett), the Clinical Study Unit (A. McAuley), the Pediatric Hematology Research Laboratory (A. Byrne), and the Department of Cardiology (Dr. Palabrica), Tufts University, Boston, MA.
Address correspondence and reprint requests to Dr. Ilonka Eisensehr, Department of Neurology, Klinikum Grosshadern, University of Munich, Marchioninistrasse 15, 81377 Munich, Germany.
Objective: There is an increased risk of patients with obstructive sleep apnea syndrome (OSAS) to have stroke or cardiac infarcts. Besides hypertension, epinephrine-induced platelet activation could be a further reason for the increased cardiovascular morbidity and mortality in OSAS.
Methods: During a 4-month period (August 1994 to December 1994) we recruited prospectively 76 patients referred for polysomnograms because of a suspected sleep disorder such as OSAS.
Results: Fifty patients had no respiratory events during sleep (non-OSAS), 19 patients had more than five but less than 50 obstructive apneas or hypopneas per hour of total sleep time (mild-to-moderate OSAS group), and seven patients had an apnea hypopnea index of more than 50 per hour of total sleep time (severe OSAS group). Blood pressure, plasma epinephrine levels, and P-selectin expression (as a marker for platelet activation) were measured in every patient at 9 PM and 6 AM (before and after the polysomnogram). There was a significant correlation of the apnea hypopnea index with 9 PM and 6 AM systolic and diastolic blood pressure, with 9 PM platelet activation, and with 6 AM epinephrine levels mainly due to high values in the severe OSAS group.
Conclusions: Our results suggest that platelet activation, epinephrine, and high blood pressure play a role in the high prevalence of cerebrovascular and cardiovascular events in patients with OSAS.
Supported by grants from the General Clinical Research Center, New England Medical Center, and Tufts University at Boston.
Received September 3, 1997. Accepted in final form March 8, 1998.
This article has been cited by other articles:
|
|
 |
|
  L. Lavie and P. Lavie Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link Eur. Respir. J., June 1, 2009; 33(6): 1467 - 1484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Lopez-Jimenez, F. H. Sert Kuniyoshi, A. Gami, and V. K. Somers Obstructive Sleep Apnea: Implications for Cardiac and Vascular Disease Chest, March 1, 2008; 133(3): 793 - 804. [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Golbin, V. K. Somers, and S. M. Caples Obstructive Sleep Apnea, Cardiovascular Disease, and Pulmonary Hypertension Proceedings of the ATS, February 15, 2008; 5(2): 200 - 206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Buyse, J. Hedner, and the participants of working group 2 Sleep apnoea, hypertension and vascular disease: where are we now? Eur. Respir. Rev., December 1, 2007; 16(106): 169 - 182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. O'Brien, L. D. Serpero, R. Tauman, and D. Gozal Plasma adhesion molecules in children with sleep-disordered breathing. Chest, April 1, 2006; 129(4): 947 - 953. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Elwood, M. Hack, J. Pickering, J. Hughes, and J. Gallacher Sleep disturbance, stroke, and heart disease events: evidence from the Caerphilly cohort J Epidemiol Community Health, January 1, 2006; 60(1): 69 - 73. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Dunleavy, M. Dooley, D. Cox, and A. Bradford Chronic intermittent asphyxia increases platelet reactivity in rats Exp Physiol, May 1, 2005; 90(3): 411 - 416. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. Olson, E. J. Olson, and V. K. Somers Obstructive Sleep Apnea and Platelet Activation: Another Potential Link Between Sleep-Disordered Breathing and Cardiovascular Disease Chest, August 1, 2004; 126(2): 339 - 341. [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Whitsett, C. J. Bachurski, K. C. Barnes, P. A. Bunn Jr., L. M. Case, D. N. Cook, D. Crooks, M. W. Duncan, L. Dwyer-Nield, R. C. Elston, et al. Functional Genomics of Lung Disease Am. J. Respir. Cell Mol. Biol., August 1, 2004; 31(2/S1): S1 - S81. [Full Text] [PDF]
|
|
|
|
|
|
D. S. Hui, F. W. Ko, J. P. Fok, M. C. Chan, T. S. Li, B. Tomlinson, and G. Cheng The Effects of Nasal Continuous Positive Airway Pressure on Platelet Activation in Obstructive Sleep Apnea Syndrome Chest, May 1, 2004; 125(5): 1768 - 1775. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Javaheri, W. T. Abraham, C. Brown, H. Nishiyama, R. Giesting, and L. E. Wagoner Prevalence of obstructive sleep apnoea and periodic limb movement in 45 subjects with heart transplantation Eur. Heart J., February 1, 2004; 25(3): 260 - 266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. von Kanel and J. E. Dimsdale Hemostatic Alterations in Patients With Obstructive Sleep Apnea and the Implications for Cardiovascular Disease Chest, November 1, 2003; 124(5): 1956 - 1967. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. M. Shamsuzzaman, B. J. Gersh, and V. K. Somers Obstructive Sleep Apnea: Implications for Cardiac and Vascular Disease JAMA, October 8, 2003; 290(14): 1906 - 1914. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. o-D. L. Lattimore, D. S. Celermajer, and I. Wilcox Obstructive sleep apnea and cardiovascular disease J. Am. Coll. Cardiol., May 7, 2003; 41(9): 1429 - 1437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S.C. Hui, D. K.L. Choy, L. K.S. Wong, F. W.S. Ko, T. S.T. Li, J. Woo, and R. Kay Prevalence of Sleep-Disordered Breathing and Continuous Positive Airway Pressure Compliance* : Results in Chinese Patients With First-Ever Ischemic Stroke Chest, September 1, 2002; 122(3): 852 - 860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. T. LEUNG and T. DOUGLAS BRADLEY Sleep Apnea and Cardiovascular Disease Am. J. Respir. Crit. Care Med., December 15, 2001; 164(12): 2147 - 2165. [Full Text] [PDF]
|
|
|
|
 |
|
 I Eisensehr, S Noachtar, M Strupp, H v Lindeiner, T Brandt, and U Buttner Absence of nystagmus during REM sleep in patients with vestibular neuritis J. Neurol. Neurosurg. Psychiatry, September 1, 2001; 71(3): 386 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Nelesen, H. Yu, M. G. Ziegler, P. J. Mills, J. L. Clausen, and J. E. Dimsdale Continuous Positive Airway Pressure Normalizes Cardiac Autonomic and Hemodynamic Responses to a Laboratory Stressor in Apneic Patients Chest, April 1, 2001; 119(4): 1092 - 1101. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. A. Purvin, A. Kawasaki, and R. D. Yee Papilledema and Obstructive Sleep Apnea Syndrome Arch Ophthalmol, December 1, 2000; 118(12): 1626 - 1630. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.A. Harbison and G.J. Gibson Snoring, sleep apnoea and stroke: chicken or scrambled egg? QJM, October 1, 2000; 93(10): 647 - 654. [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Hart, D. J. Hole, and G. D. Smith Comparison of Risk Factors for Stroke Incidence and Stroke Mortality in 20 Years of Follow-Up in Men and Women in the Renfrew/Paisley Study in Scotland Stroke, August 1, 2000; 31(8): 1893 - 1896. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Eisensehr, R. Linke, S. Noachtar, J. Schwarz, F. J. Gildehaus, and K. Tatsch Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder: Comparison with Parkinson's disease and controls Brain, June 1, 2000; 123(6): 1155 - 1160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Narkiewicz, M. Kato, B. G. Phillips, C. A. Pesek, D. E. Davison, and V. K. Somers Nocturnal Continuous Positive Airway Pressure Decreases Daytime Sympathetic Traffic in Obstructive Sleep Apnea Circulation, December 7, 1999; 100(23): 2332 - 2335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. C. Roman New Insight Into Binswanger Disease Arch Neurol, September 1, 1999; 56(9): 1061 - 1062. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
